Winners of venture kick stage 2 revealed
14.08.2013
DEPsys and Cacification Prevention are the winners of venture kick’s second stage. They obtained CHF 20’000. – of pre-seed capital and are qualified for the next stage to win, if they are successful, CHF 100’000.- more.
![]() Michael De Vivo, DEPsys co-founder.
|
![]() |
![]() Matthias Meier, Calcisco co-founder.
|
![]() |
Michael De Vivo, DEPsys co-founders and venturelab alumni, obtained his Master of science in engineering at HEIG-VD in 2011. He launched DEPsys with Joël Jaton and Guillaume Besson. They try to prevent failures on the low-voltage grid, thanks to a new product, called IGI module. This module will help the stabilization of the low-voltage grid profile, making use of the DER (Distributed Energy Resources) inverters Real and Reactive Power capabilities.
CALCISCO AG
Cardiovascular disease due to vascular and soft tissue calcifications is a major cause of death worldwide. Matthias Meier, CALCISCO co-founder, is actually Scientific Project Manager at University of Zürich in the Institute of Physiology. Together with Dr. Andreas Pasch, co-founder and inventor of the novel test, they will commercialize the first diagnostic blood test capable to identify patients at elevated risk to develop pathologic calcifications. In parallel, new therapies for the prevention of calcification will be developed.
CALCISCO AG
Cardiovascular disease due to vascular and soft tissue calcifications is a major cause of death worldwide. Matthias Meier, CALCISCO co-founder, is actually Scientific Project Manager at University of Zürich in the Institute of Physiology. Together with Dr. Andreas Pasch, co-founder and inventor of the novel test, they will commercialize the first diagnostic blood test capable to identify patients at elevated risk to develop pathologic calcifications. In parallel, new therapies for the prevention of calcification will be developed.
CONGRATULATIONS TO BOTH OF THEM